外用药物市场规模、份额和成长分析（按给药途径、类型、最终用途和地区）- 产业预测 2025-2032

2023 年外用药物市场规模价值 1,905 亿美元，预计将从 2024 年的 2019.3 亿美元成长到 2032 年的 3,218.5 亿美元，预计在预测期内（2025-2032 年）的复合年增长率为 6.0%。

随着人们对护肤的认识不断提高以及对各种皮肤病的局部治疗需求的增加，外用药物市场正在经历显着增长。消费者正在积极寻求解决痤疮、湿疹、干癣、衰老征兆像等问题的解决方案，从而推动了对具有针对性治疗功效的止痛膏和经皮吸收贴片的需求。药物配方和给药方法的创新正在推动製药公司开发新的外用产品，以满足不同的医疗和美容需求。此外，人们对护肤中天然和有机成分的偏好日益增长，以及对安全性和功效的高度关注，进一步增强了市场前景。总体而言，随着研发工作不断产生新的治疗方法以及消费者越来越重视皮肤健康和保健，全球外用药物市场预计将继续扩大。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

外用药物市场规模（依给药途径及复合年增长率） (2025-2032)

• 市场概况
• 皮肤
• 眼科
• 直肠
• 阴道
• 鼻腔

外用药物市场规模（按类型和复合年增长率） (2025-2032)

• 市场概况
• 半固体
• 经皮

外用药物市场规模（按最终用途和复合年增长率划分）（2025-2032 年）

• 市场概况
• 医院
• 诊所
• 居家环境

外用药物市场规模（按地区划分）及复合年增长率（2025-2032 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Glenmark Pharmaceuticals Ltd.（India）
• Johnson & Johnson Private Limited（USA）
• GlaxoSmithKline PLC（UK）
• Bausch Health Companies Inc.（Canada）
• Cipla Ltd.（India）
• Bayer AG（Germany）
• 3M（USA）
• Merck & Co., Inc.（USA）
• Crescita Therapeutics Inc.（Canada）
• Novartis International AG（Switzerland）
• Taro Pharmaceutical Industries Ltd.（Israel）
• Valeant Pharmaceuticals International Inc.（Canada）
• Encore Dermatology Inc.（USA）
• Medpharm Group Limited（UK）
• SkinVisible Pharmaceuticals Inc.（USA）
• Hisamitsu Pharmaceutical Co., Inc.（Japan）
• Pfizer Inc.（USA）
• Sanofi（France）
• Teva Pharmaceutical Industries Ltd.（Israel）

结论和建议

Topical Drugs Market size was valued at USD 190.5 billion in 2023 and is poised to grow from USD 201.93 billion in 2024 to USD 321.85 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).

The topical drug market is experiencing significant growth, fueled by an increasing awareness of skincare and the need for localized treatments for various dermatological conditions. Consumers are actively seeking solutions for issues such as acne, eczema, psoriasis, and aging signs, driving demand for pain relief creams and transdermal patches due to their targeted therapeutic benefits. Innovation in drug formulations and delivery methods is prompting pharmaceutical companies to develop new topical products that cater to diverse medical and cosmetic needs. Additionally, the rising preference for natural and organic ingredients in skincare is further enhancing the market landscape, with a strong focus on safety and effectiveness. Overall, the global topical drug market is poised for continued expansion as R&D efforts yield new treatments and consumers increasingly prioritize skin health and wellness.

Top-down and bottom-up approaches were used to estimate and validate the size of the Topical Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Topical Drugs Market Segments Analysis

Global Topical Drugs Market is segmented by Route of Administration, Type, End Use and region. Based on Route of Administration, the market is segmented into Dermal, Ophthalmic, Rectal, Vaginal and Nasal. Based on Type, the market is segmented into Semi-solid and Transdermal. Based on End Use, the market is segmented into Hospitals, Clinics and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Topical Drugs Market

A significant factor propelling the growth of the topical drugs market is the aging population. As the global demographic continues to age, there is an increasing need for skin care and dermatological treatments that address age-related skin concerns. Furthermore, the rising awareness regarding skin health, combined with a desire for a youthful appearance, is leading consumers to seek topical solutions, thereby driving market expansion. This trend reflects a heightened interest in maintaining skin vitality and combating visible signs of aging, which ultimately supports the growth of the topical drugs market and highlights the importance of innovative solutions in this sector.

Restraints in the Topical Drugs Market

The process of obtaining approval for topical medications often involves lengthy and costly procedures, necessitating extensive clinical trials and rigorous safety evaluations. Such regulatory requirements can significantly slow down the development of new products and hinder their entry into the market. As a result, pharmaceutical companies face substantial challenges in delivering innovative topical drugs, given the financial and time investments required to navigate these stringent approval processes. This situation represents a considerable restraint for the topical drugs market, as these barriers can limit the availability of new treatments, impacting both businesses and consumers seeking effective solutions.

Market Trends of the Topical Drugs Market

The Topical Drugs market is poised for significant growth, driven by the rise of telemedicine and e-pharmacies, which have revolutionized patient access to dermatological care. As healthcare shifts towards digital solutions, consumers increasingly favor the convenience and immediacy of receiving consultations online, leading to a surge in prescriptions for topical treatments. The demand for contactless healthcare solutions, alongside a growing inclination to purchase medications via digital channels, underpins this trend. As e-pharmacy platforms evolve and telehealth services expand, the market for topical drugs is expected to prosper, reflecting broader changes in consumer habits and healthcare delivery systems.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Topical Drugs Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Dermal
• Ophthalmic
• Rectal
• Vaginal
• Nasal

Global Topical Drugs Market Size by Type & CAGR (2025-2032)

• Market Overview
• Semi-solid
• Transdermal

Global Topical Drugs Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Home Care Settings

Global Topical Drugs Market Size & CAGR (2025-2032)

• North America (Route of Administration, Type, End Use)
  • US
  • Canada
• Europe (Route of Administration, Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Route of Administration, Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Route of Administration, Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Route of Administration, Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Glenmark Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Private Limited (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crescita Therapeutics Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taro Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeant Pharmaceuticals International Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Encore Dermatology Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpharm Group Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SkinVisible Pharmaceuticals Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hisamitsu Pharmaceutical Co., Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations